ロード中...
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Only a subgroup of patients with muscle-invasive bladder cancer (MIBC) are responders toward cisplatin-based chemotherapy and PD-L1 blockade immunotherapy. There is a clinical need to identify MIBC molecular subtypes and biomarkers for patient stratification toward the therapies. Here, we performed...
保存先:
| 出版年: | Commun Biol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7746703/ https://ncbi.nlm.nih.gov/pubmed/33335285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-01491-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|